04:26 PM EDT, 03/12/2025 (MT Newswires) -- W. Michael Flanagan, Chief Scientific Officer, on March 11, 2025, sold 20,000 shares in Avidity Biosciences ( RNA ) for $602,614. Following the Form 4 filing with the SEC, Flanagan has control over a total of 91,975 common shares of the company, with 91,975 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1599901/000159990125000063/xslF345X05/wk-form4_1741811027.xml